Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Shiro Takami"'
Autor:
Takahisa Kawaguchi, Toshihide Shima, Masayuki Mizuno, Yasuhide Mitsumoto, Atsushi Umemura, Yoshihiro Kanbara, Saiyu Tanaka, Yoshio Sumida, Kohichiro Yasui, Meiko Takahashi, Keitaro Matsuo, Yoshito Itoh, Katsutoshi Tokushige, Etsuko Hashimoto, Kendo Kiyosawa, Masanori Kawaguchi, Hiroyuki Itoh, Hirofumi Uto, Yasuji Komorizono, Ken Shirabe, Shiro Takami, Toshinari Takamura, Miwa Kawanaka, Ryo Yamada, Fumihiko Matsuda, Takeshi Okanoue
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0185490 (2018)
The genetic factors affecting the natural history of nonalcoholic fatty liver disease (NAFLD), including the development of nonalcoholic steatohepatitis (NASH) and NASH-derived hepatocellular carcinoma (NASH-HCC), are still unknown. In the current st
Externí odkaz:
https://doaj.org/article/6b653d846bff4fc2b98baf37577fb9b0
Autor:
Toshihide Shima, Kohichiroh Yasui, Yasuyuki Nagao, Yoshito Itoh, Saiyu Tanaka, Hideki Nakamura, Hiroyuki Kimura, Hideki Fujii, Kanji Yamaguchi, Hiroki Ishikawa, Atsushi Umemura, Taichiro Nishikawa, Masahito Minami, Michihisa Moriguchi, Shiro Takami
Publikováno v:
World Journal of Hepatology
AIM To investigate daclatasvir (DCV) and asunaprevir (ASV) efficacy in hepatitis C (HCV) patients, with respect to resistance-associated substitutions (RASs). METHODS A total of 392 HCV-infected patients from multiple centers were included in this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36dd6b7fcd561ae0c88472f36a80e09b
http://europepmc.org/articles/PMC5596313
http://europepmc.org/articles/PMC5596313
Autor:
Kento, Hikita, Shiro, Takami, Hiroko, Sugimoto, Hidenori, Kimura, Noriko, Tanaka, Jun, Nakajima, Hiroyuki, Yoriki, Masayasu, Jo, Keika, Zen, Akira, Masuzawa, Naoyuki, Matsumoto, Naoki, Wakabayashi, Keisho, Kataoka, Naoko, Masuzawa
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 115(9)
A man in his 70s was referred to our hospital for evaluation of low-grade fever, weight loss, and liver dysfunction. Serological tests for viral hepatitis or autoimmune diseases were negative. No significant findings were observed on whole-body compu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5223eefd75c68bf4e801e6f4c0b46c7e
https://pubmed.ncbi.nlm.nih.gov/30197396
https://pubmed.ncbi.nlm.nih.gov/30197396
Autor:
Yasuji Komorizono, Toshinari Takamura, Kohichiro Yasui, Keitaro Matsuo, Yoshito Itoh, Toshihide Shima, Yoshihiro Kanbara, Yoshio Sumida, Yasuhide Mitsumoto, Masanori Kawaguchi, Hirofumi Uto, Ken Shirabe, Masayuki Mizuno, Takahisa Kawaguchi, Takeshi Okanoue, Atsushi Umemura, Fumihiko Matsuda, Katsutoshi Tokushige, Etsuko Hashimoto, Ryo Yamada, Hiroyuki Itoh, Kendo Kiyosawa, Miwa Kawanaka, Meiko Takahashi, Saiyu Tanaka, Shiro Takami
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 1, p e0185490 (2018)
PLoS ONE, Vol 13, Iss 1, p e0185490 (2018)
The genetic factors affecting the natural history of nonalcoholic fatty liver disease (NAFLD), including the development of nonalcoholic steatohepatitis (NASH) and NASH-derived hepatocellular carcinoma (NASH-HCC), are still unknown. In the current st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1801c0ca48826b5a27d032a02e9078
http://hdl.handle.net/2433/229128
http://hdl.handle.net/2433/229128
Autor:
Toshihiko Kirishima, Rei Sendo, Hideki Fujii, Masayuki Mizuno, Kohichiroh Yasui, Takeshi Okanoue, Kanji Yamaguchi, Hiroyuki Shintani, Toshihisa Niimi, Takahiro Mori, Yoshio Sumida, Masahito Minami, Yoshito Itoh, Toshihide Shima, Saiyu Tanaka, Jun Funaki, Takayuki Katayama, Masayasu Jo, Hiroyuki Kimura, Yasuhide Mitsumoto, Naomi Yoshinami, Shiro Takami, Keizo Kagawa
Publikováno v:
Hepatology Research. 44:1329-1338
Aim Sorafenib is the standard systemic therapy for patients with advanced hepatocellular carcinoma (HCC). We aimed to assess the efficacy and safety of sorafenib therapy in very elderly patients aged 80 years and older with advanced HCC. Methods In a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac3c3fd353495e6e56b0d83f986c58a4
https://doi.org/10.1111/hepr.12308
https://doi.org/10.1111/hepr.12308
Autor:
Kohichiroh Yasui, Yasuji Komorizono, Takeshi Okanoue, Kazuhiko Koike, Etsuko Hashimoto, Yoshihiro Kanbara, Toshiji Saibara, Toshihide Shima, Shiro Takami, Miwa Kawanaka, Katsutoshi Tokushige, Hirofumi Uto
Publikováno v:
Hepatology Research. 42:767-773
Aim: Non-alcoholic steatohepatitis (NASH) can progress to hepatocellular carcinoma (HCC). We aimed to examine the clinical and pathological course of how NASH progresses to HCC. Methods: In this retrospective multicenter study conducted in Japan, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67341a0c868ef132470c97a4d0104bfc
https://doi.org/10.1111/j.1872-034x.2012.00986.x
https://doi.org/10.1111/j.1872-034x.2012.00986.x
Autor:
Kohichiroh Yasui, Yoshihiro Kanbara, Shiro Takami, Takahiro Mori, Toshinari Takamura, Etsuko Hashimoto, Toshihide Shima, Miwa Kawanaka, Hirofumi Uto, Sumio Kawata, Shigeki Arii, Toshiji Saibara, Takeshi Okanoue, Yasuharu Imai, Yoshio Sumida, Kazuhiko Koike, Yasuji Komorizono
Publikováno v:
Clinical Gastroenterology and Hepatology. 9:428-433
Background & Aims Nonalcoholic steatohepatitis (NASH) can progress to hepatocellular carcinoma (HCC). We aimed to characterize the clinical features of NASH patients with HCC. Methods In a cross-sectional multicenter study in Japan, we examined 87 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e44cd9179c9d3e849e6e79c274ec9e
https://doi.org/10.1016/j.cgh.2011.01.023
https://doi.org/10.1016/j.cgh.2011.01.023
Autor:
Kohichiroh Yasui, Hironori Mitsuyoshi, Takayuki Takeuchi, Yoshio Sumida, Yasuyuki Nagao, Yoshihiko Sawa, Hiroki Ishikawa, Toshihide Shima, Kanji Yamaguchi, Chihiro Yokomizo, Shiro Takami, Taichiro Nishikawa, Hiroyuki Kimura, Saiyu Tanaka, Masahito Minami, Atsushi Umemura, Takeshi Nishimura, Michihisa Moriguchi, Yoshito Itoh, Hideki Fujii, Kenichi Nishioji
Publikováno v:
World journal of hepatology. 7(28)
To compare efficacy of telaprevir (TVR) and simeprevir (SMV) combined with pegylated interferon (PEG-IFN) and ribavirin (RBV) while treating chronic hepatitis C (CHC).In all, 306 CHC patients were included in this study. There were 159 patients in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b89c7cf7023164d035eadf217d0ff40
https://pubmed.ncbi.nlm.nih.gov/26668696
https://pubmed.ncbi.nlm.nih.gov/26668696
Autor:
Naoto, Iwai, Naoki, Wakabayashi, Naoyuki, Matsumoto, Yukihiro, Morita, Noriko, Tanaka, Hiroyuki, Yoriki, Kota, Fujii, Ryusuke, Takada, Hiroki, Takaya, Akira, Masuzawa, Shiro, Takami, Keisho, Kataoka
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(3)
Fifteen years after receiving a distal gastrectomy for advanced gastric cancer, a 70-year-old woman was admitted to our hospital because of abdominal fullness due to ascites. Although cytological examination showed adenocarcinoma cells in the fluid,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e46042cdc05791680b3527d6d894f52b
https://pubmed.ncbi.nlm.nih.gov/25812506
https://pubmed.ncbi.nlm.nih.gov/25812506
Autor:
Katsuya Nakano, Toshikazu Nakajima, Masayuki Imamura, Shiro Takami, Masako Fukuda, Koichi Tomikashi
Publikováno v:
Journal of Gastroenterology and Hepatology. 21:1502-1505
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39803637814396c94ecb5fe22fdd61de
https://doi.org/10.1111/j.1440-1746.2006.04347.x
https://doi.org/10.1111/j.1440-1746.2006.04347.x